HanAll Biopharma Co., Ltd. (009420):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:HanAll Biopharma Co., Ltd. (009420) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81901FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

HanAll Biopharma Co., Ltd. (HanAll) is a pharmaceutical company. The company’s activities include drug delivery, biotherapeutics, and small molecule discovery. Its research and development pipeline includes HL156Can, HL152B, HL156Fib, hanferon, HL036 topical TNF-alpha inhibitor, HL161 anti-FcRn mAb, HL009-adenosyl-B12 liposomal gel, Hl040-atorvastain+losartan, and oral vitatropin. It also exports its products, such as glucodown tab, hanall glimepiride tab, refosporen injection, tomiporan injection, and many more. HanAll provides research and development in the areas of oncology, fibrotic diseases, ophthalmology, immunology, endocrinology, and cardiovascular disease. The company partners with many other pharmaceutical companies for the development and distribution of different products. The company has its business development office in the US. The company was formerly known as HanAll Pharmaceutical Co., Ltd. HanAll is headquartered in Songpa-Gu, Seoul, Korea.

HanAll Biopharma Co., Ltd. Key Recent Developments

Jun 14, 2013: Hanall Biopharma Receives Patent For N, N-dimethyl Imidodicarbonimidic Diamide Acetate In Japan
Jun 04, 2013: Hanall Biopharma Receives Patent Covering Deformed Human Tumor Necrosis Factor
Feb 20, 2013: Hanall Biopharma Secures New US Patent For Controlled Release Complex Composition
Jan 22, 2013: Hanall Biopharma Obtains New Patent

This comprehensive SWOT profile of HanAll Biopharma Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of HanAll Biopharma Co., Ltd. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

HanAll Biopharma Co., Ltd. – Key Information
HanAll Biopharma Co., Ltd. – Overview
HanAll Biopharma Co., Ltd. – Key Employees
HanAll Biopharma Co., Ltd. – Key Employee Biographies
HanAll Biopharma Co., Ltd. – Key Operational Heads
HanAll Biopharma Co., Ltd. – Major Products and Services
HanAll Biopharma Co., Ltd. – History
HanAll Biopharma Co., Ltd. – Company Statement
HanAll Biopharma Co., Ltd. – Locations And Subsidiaries
HanAll Biopharma Co., Ltd. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

HanAll Biopharma Co., Ltd. – Business Description
HanAll Biopharma Co., Ltd. – Corporate Strategy
HanAll Biopharma Co., Ltd. – SWOT Analysis
SWOT Analysis – Overview
HanAll Biopharma Co., Ltd. – Strengths
HanAll Biopharma Co., Ltd. – Weaknesses
HanAll Biopharma Co., Ltd. – Opportunities
HanAll Biopharma Co., Ltd. – Threats
HanAll Biopharma Co., Ltd. – Key Competitors

Section 3 – Company Financial Performance Charts

HanAll Biopharma Co., Ltd. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

HanAll Biopharma Co., Ltd., Key Information
HanAll Biopharma Co., Ltd., Key Ratios
HanAll Biopharma Co., Ltd., Share Data
HanAll Biopharma Co., Ltd., Major Products and Services
HanAll Biopharma Co., Ltd., History
HanAll Biopharma Co., Ltd., Key Employees
HanAll Biopharma Co., Ltd., Key Employee Biographies
HanAll Biopharma Co., Ltd., Key Operational Heads
HanAll Biopharma Co., Ltd., Other Locations
HanAll Biopharma Co., Ltd., Subsidiaries
HanAll Biopharma Co., Ltd., Key Manufacturing facilities
HanAll Biopharma Co., Ltd., Key Competitors
HanAll Biopharma Co., Ltd., SWOT Analysis
HanAll Biopharma Co., Ltd., Ratios based on current share price
HanAll Biopharma Co., Ltd., Annual Ratios
HanAll Biopharma Co., Ltd., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

HanAll Biopharma Co., Ltd., Performance Chart
HanAll Biopharma Co., Ltd., Ratio Charts

★海外企業調査レポート[HanAll Biopharma Co., Ltd. (009420):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Honeywell International Inc.:企業の戦略・SWOT・財務分析
    SummaryHoneywell International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company …
  • Capital City Bank Group, Inc.:企業の戦略・SWOT・財務分析
    SummaryCapital City Bank Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compan …
  • Sulzer Ltd (SUN):企業の財務及び戦略的SWOT分析
    Sulzer Ltd (SUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • IDB Development Corporation, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' IDB Development Corporation, Lt …
  • Nippon Flour Mills Co., Ltd.:企業の戦略・SWOT・財務分析
    Nippon Flour Mills Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Flour Mills Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Sanbian Sci-Tech Co., Ltd. (002112):企業概要、財務及び戦略的SWOT分析
    Summary Sanbian Sci-Tech Co., Ltd. (Sanbian) is an electrical equipment manufacturing company. The company designs, develops, manufactures and distributes large and medium size transformers. Its products include oil immersed transformer, dry type transformer, combined transformer substation, combine …
  • JW Pharmaceutical Corporation (001060)(製薬・医療分野):企業M&A動向
    Summary JW Pharmaceutical Corporation (JW Pharmaceutical) is a pharmaceutical company. The company develops, produces and markets analgesics, antipyretics and cold remedy, antidote agents, antimicrobials, anticancer agents, antifungal agents, cardiovascular agents, gastrointestinla agents, miscellan …
  • SSE plc (formerly Scottish and Southern Energy plc):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' SSE plc (formerly Scottish and …
  • China Communications Services Corporation Limited (552):企業の財務及び戦略的SWOT分析
    Summary China Communications Services Corporation Limited (CCSCL) subsidiary of China Telecom Corporation Limited is a technology company that offers telecommunication support services. The company provides telecommunications infrastructure services, business process outsourcing services, and applic …
  • Colabor Group, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Colabor Group, Inc. Mergers and …
  • QSGI, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' QSGI, Inc. Mergers and Acquisit …
  • Sprott Resource Corp. (SCP):企業の財務及び戦略的SWOT分析
    Summary Sprott Resource Corp. (SRC), formerly General Minerals Corporation is an energy investment company that invests and operates in oil and gas, agriculture and agricultural nutrients. The company’s investments include Gold Bullion, PBS Coals, Silver Bullion, Waseca Energy Inc., Stonegate Agrico …
  • NeuroMetrix, Inc. (NURO):企業のM&A・提携動向(医療機器分野)
    Summary NeuroMetrix, Inc. (NeuroMetrix) is a medical device company that focuses on the development of home use and point-of-care devices for the management of chronic pain, peripheral neuropathies, and associated neurological disorders. It offers two product lines: Wearable neurostimulation devices …
  • Palmer and Harvey McLane Limited:企業の戦略・SWOT・財務分析
    SummaryPalmer and Harvey McLane Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the com …
  • API Healthcare Corporation:企業のM&A・提携動向(医療機器分野)
    Summary API Healthcare Corporation (API Healthcare) is a subsidiary of GE Healthcare Systems, a healthcare organization that provides workforce management solutions for the healthcare industry. It offers solutions for health systems and staffing agencies, such as staffing and scheduling, patient cla …
  • Zargon Energy Trust:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Zargon Energy Trust Mergers and …
  • Sosei Group Corporation(製薬・医療分野):企業M&A動向
    Summary Sosei Group Corporation (Sosei) is a biopharmaceutical company. The company develops and commercializes drugs. Its products include NorLevo, NVA237, QVA149 and SO-1105. The company’s NorLevo product is an oral emergency contraceptive and SO-1105 is an antifungal agent, administered as a muco …
  • OAO NOVATEK:企業のM&A・提携・投資分析
    OAO NOVATEK - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's OAO NOVATEK Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • GL Limited (B16):企業財務及び戦略的SWOT分析
    Summary GL Limited (GL), formerly GuocoLeisure Limited is a subsidiary of Guoco Group Limited, financial service provider that offers investment services. The company offers investments in hotel management and operations, gaming, oil and gas, property development, and other areas in the leisure indu …
  • TogliattiAzot (TLAZ):企業概要、財務及び戦略的SWOT分析
    Summary Togliattiazot (Togliattiazot) is a chemical company. The company produces mineral fertilizers such as ammonia and urea. Its products include ammonia, carbonic dioxide, carbamide, carbamide-formaldehyde concentrate (CFC), basalt fiber and film, refractory materials and frit, ceramic productio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆